NICE backs narrowed Efient use

The U.K.'s NICE issued guidance recommending the use of cardiovascular drug Efient prasugrel from Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) and Eli Lilly and Co. (NYSE:LLY) in a patient populat...